These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1946070)

  • 1. [Oral hygiene in subjects treated with diphenylhydantoin: effects of a professional program].
    Francetti L; Maggiore E; Marchesi A; Ronchi G; Romeo E
    Prev Assist Dent; 1991; 17(3):40-3. PubMed ID: 1946070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of professional oral hygiene in patients undergoing diphenylhydantoin therapy: research protocol and preliminary results].
    Weinstein R; Gandolfi F; Matarasso S; Zarone F
    Mondo Odontostomatol; 1986; 28(5):59-66. PubMed ID: 2946942
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tooth health, drugs, and gingival hyperplasia].
    Munthe-Kaas A; Storhaug K
    Tidsskr Nor Laegeforen; 1978 Jan; 98(3):161-2. PubMed ID: 628914
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of a plaque control program on the development of phenytoin-induced gingival overgrowth. A 2-year longitudinal study.
    Dahllöf G; Modéer T
    J Clin Periodontol; 1986 Oct; 13(9):845-9. PubMed ID: 3465754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of phenytoin associated gingival enlargement--a 15-month longitudinal study.
    Pihlstrom BL; Carlson JF; Smith QT; Bastien SA; Keenan KM
    J Periodontol; 1980 Jun; 51(6):311-7. PubMed ID: 6930469
    [No Abstract]   [Full Text] [Related]  

  • 6. The reduction of phenytoin-induced gingival overgrowth in a severely disabled patient: a case report.
    Fitchie JG; Comer RW; Hanes PJ; Reeves GW
    Compendium; 1989 Jun; 10(6):314, 317-20. PubMed ID: 2605605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dilantin hyperplasia: a preventable lesion?
    Hall WB
    Compend Suppl; 1990 Mar; (14):S502-5. PubMed ID: 2097043
    [No Abstract]   [Full Text] [Related]  

  • 8. Office management of phenytoin-induced gingival overgrowth.
    Steinberg AD
    Compend Contin Educ Dent (Lawrenceville); 1985 Feb; 6(2):138-42, 145-7. PubMed ID: 3855742
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention and treatment of Dilantin-associated gingival enlargement.
    Pihlstrom BL
    Compend Suppl; 1990 Mar; (14):S506-10. PubMed ID: 2097044
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of chlorhexidine and mechanical methods of plaque control on the recurrence of gingival hyperplasia in young patients taking phenytoin.
    O'Neil TC; Figures KH
    Br Dent J; 1982 Feb; 152(4):130-3. PubMed ID: 6462158
    [No Abstract]   [Full Text] [Related]  

  • 11. Diphenylhydantoin gingival hyperplasia in Macaca arctoides: prevention by inhibition of dental plaque deposition.
    Staple PH; Reed MJ; Mashimo PA; Sedransk N; Umemoto T
    J Periodontol; 1978 Jun; 49(6):310-25. PubMed ID: 100589
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonsurgical Management of Phenytoin-induced Gingival Hyperplasia.
    AlJehani YA
    J Contemp Dent Pract; 2015 Apr; 16(4):319-21. PubMed ID: 26067737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The measured effect of phenytoin withdrawal on gingival hyperplasia in children.
    Brunsvold M; Tomasovic J; Ruemping D
    ASDC J Dent Child; 1985; 52(6):417-21. PubMed ID: 3864798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe phenytoin-induced gingival enlargement associated with periodontitis.
    Lucchesi JA; Cortelli SC; Rodrigues JA; Duarte PM
    Gen Dent; 2008; 56(2):199-203; quiz 204-5, 224. PubMed ID: 18348382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factors involved in gingival hyperplasia caused by diphenyl hydantoin].
    Mattioli A; Mauro S; Menetti L; Orlando S
    Minerva Stomatol; 1997 Oct; 46(10):525-32. PubMed ID: 9432558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlorhexidine as an oral hygiene adjunct for cyclosporine-induced gingival hyperplasia.
    Saravia ME; Svirsky JA; Friedman R
    ASDC J Dent Child; 1990; 57(5):366-70. PubMed ID: 2212196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gingival hyperplasia due to diphenylhydantoin. Anatomo-clinical study of a case].
    Latorre G; Carrozza G; Busà S; Calabrò S; Briguglio R
    Stomatol Mediterr; 1986; 6(4):483-8. PubMed ID: 2955528
    [No Abstract]   [Full Text] [Related]  

  • 18. Phenytoin hyperplasia occurring in relation to titanium implants: a clinical report.
    Chee WW; Jansen CE
    Int J Oral Maxillofac Implants; 1994; 9(1):107-9. PubMed ID: 8150508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dilantin gingival hyperplasia: patient evaluation in relation to anticonvulsant dosage, degree of oral hygiene and extension of lesion].
    Pugliesi NS; da Silva FT; Saleh ER; Biagini VS; Marin de los Rios C; Rode Sde M
    Rev Faculdade Odontol FZL; 1989; 1(2):97-103. PubMed ID: 2485648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gingival hyperplasia and diphenylhydantoin].
    Barone GP; Arata E; Salmeri S; Patrone M
    Parodontol Stomatol (Nuova); 1984; 23(3 Suppl 3):149-55. PubMed ID: 6443491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.